fbpx

Cotización de LTRN Noticias y Datos Financieros de Lantern Pharma Inc

  ESCÁNER DE ACCIONES AMERICANAS DE TRADINGCERO.COM (VERSIÓN 1.0)      Hora Nueva York:
(2022-07-04)Formato Y-M-D
EARNINGS AYER: Ayer no hubo informes de resultados.
EARNINGS HOY: No hay informes de resultados previstos para hoy.
EARNINGS MAÑANA: No hay informes de resultados previstos para mañana.
IPOS AYER: Ayer no hubo IPOS.
IPOS HOY: No hay IPOS previstas para hoy.
IPOS MAÑANA: No hay IPOS previstas para mañana.
  
[ Escáners ]  1. Escáner de TODAS las Acciones.
  2. Escáner de PennyStocks (<= $10).
  3. Escáner de SmallCaps ($10 < y <= $80).
  4. Escáner de LargeCaps ( > $80).
     
[ Screener ]  >> Screener de TradingCero.com
     
[ Calendario de Earnings ]  >> Empresas que publicarán sus Informes de Resultados próximamente
     
[ Calendario de IPOS ]  >> Empresas que debutarán en WallStreet próximamente
     
[ Industrias / Sectores ]  >> Listado de Insdustrias y Sectores en WallStreet
     
[ Panel Predictivo ]  >> Acceso restringido
     
[ Descarga de Informes ]  >> Acceso restringido
     
[ Registro de Cambios ]  >> Registro de Cambios en el Escáner.
     

[ PÁGINA ACTUALIZADA EL 2022-07-04 23:20:55 hrs (New York) ]

Nombre:Nombre de la Empresa, Número de Empleados y web si está disponible
     Lantern Pharma Inc     Empleados: 13     Web Disponible
Industria:Industria a la que pertenece la Empresa
     Pharmaceutical Preparation Manufacturing
Sector:Sector al que pertenece la Empresa
     Manufacturing
Market Cap.:Capitalización de Mercado de la Empresa
     60.64 M
Insider Own:Porcentaje de Acciones que poseen los Socios de la Empresa
     18.7 %
Shares:Número total de Acciones de la Empresa
     10.88 M
Float:Flotante (Acciones disponibles para comprar/vender) de la Empresa
     8.8 M
Short Float:Porcentaje de Acciones en Corto de los Inversores sobre la Empresa
     1.02 %
Volumen:Volumen de operaciones de la última sesión de mercado sobre la Empresa
     0.01 M
Vol. Medio:Volumen Medio Diario de operaciones realizadas en el Mercado sobre la Empresa
     0.02345 M
Último %:Cambio en porcentaje: Diario, Semanal, Mensual y Anual de la Empresa
     -1.6 %     Semanal %:     15.59 %     Mensual %:   -1.38 %     Anual %:   1 %
TODAS LAS NOTICIAS DE [ LTRN ]
FECHA / HORA     ÚLTIMAS NOTICIAS
2022-05-12 07:00:00    
>> Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme GBM with Collaborators from Johns Hopkins during Brain Tumor Awareness Month ...Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme GBM with Collaborators from Johns Hopkins during Brain Tumor Awareness Month
2022-05-06 10:29:00    
>> We re Not Very Worried About Lantern Pharma s NASDAQ LTRN Cash Burn Rate ...We re Not Very Worried About Lantern Pharma s NASDAQ LTRN Cash Burn Rate
2022-05-05 08:00:00    
>> LTRN First Quarter 2022 Financial and Operational Results ...LTRN First Quarter 2022 Financial and Operational Results
2022-05-05 07:00:00    
>> Lantern Pharma Management to Speak at Multiple Investor and Scientific Conferences in May 2022 ...Lantern Pharma Management to Speak at Multiple Investor and Scientific Conferences in May 2022
2022-05-03 16:01:00    
>> Lantern Pharma Reports First Quarter 2022 Financial Results and Operational Highlights ...Lantern Pharma Reports First Quarter 2022 Financial Results and Operational Highlights
2022-04-26 07:15:00    
>> Lantern Pharma s Board of Directors Names Maria Maccecchini Ph D as a Director Nominee to Lantern s Board of Directors ...Lantern Pharma s Board of Directors Names Maria Maccecchini Ph D as a Director Nominee to Lantern s Board of Directors
2022-04-22 07:00:00    
>> Lantern Pharma to Report First Quarter 2022 Operating amp Financial Results on May 3rd 2022 at 4 30 p m ET ...Lantern Pharma to Report First Quarter 2022 Operating amp Financial Results on May 3rd 2022 at 4 30 p m ET
2022-04-14 11:10:00    
>> Lantern Pharma Interview to Air on Bloomberg U S on the RedChip Money Report R ...Lantern Pharma Interview to Air on Bloomberg U S on the RedChip Money Report R
2022-03-22 07:00:00    
>> Lantern Pharma Announces Extension of Existing Share Repurchase Program ...Lantern Pharma Announces Extension of Existing Share Repurchase Program
2022-03-14 07:00:00    
>> Lantern Pharma to Present Positive Preclinical Data on the Effectiveness of LP 184 in Brain Metastases at the American Association of Cancer Research ...Lantern Pharma to Present Positive Preclinical Data on the Effectiveness of LP 184 in Brain Metastases at the American Association of Cancer Research AACR Annual Meeting
2022-03-14 06:38:00    
>> LTRN 2021 Results ...LTRN 2021 Results
2022-03-10 16:05:00    
>> Lantern Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Operational Highlights ...Lantern Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Operational Highlights
2022-03-03 07:00:00    
>> Lantern Pharma Inc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10 2022 ...Lantern Pharma Inc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10 2022
2022-02-15 06:59:00    
>> Lantern Pharma Expands into Additional Pediatric Cancers Through a Collaboration with The Greehey Children s Cancer Research Institute GCCRI at Univ ...Lantern Pharma Expands into Additional Pediatric Cancers Through a Collaboration with The Greehey Children s Cancer Research Institute GCCRI at University of Texas Health Science Center San Antonio
2022-02-02 17:38:00    
>> Sanders Morris Harris Llc Buys Roth CH Acquisition V Co The Walt Disney Co Mastercard Inc ...Sanders Morris Harris Llc Buys Roth CH Acquisition V Co The Walt Disney Co Mastercard Inc
2022-01-26 16:30:00    
>> RedChip Partners with Benzinga to Host Exclusive Small Cap CEO Interview Series on January 28 ...RedChip Partners with Benzinga to Host Exclusive Small Cap CEO Interview Series on January 28
2022-01-24 07:00:00    
>> Lantern Pharma Receives Rare Pediatric Disease and Orpan Drug Designations for LP 184 for the Treatment of Atypical Teratoid Rhabdoid Tumor ATRT a ...Lantern Pharma Receives Rare Pediatric Disease and Orpan Drug Designations for LP 184 for the Treatment of Atypical Teratoid Rhabdoid Tumor ATRT an Aggressive and Rapidly Growing Form of Cancer of the Central Nervous System
2022-01-20 08:04:00    
>> LTRN Multiple Collaborations Illuminating Way Forward ...LTRN Multiple Collaborations Illuminating Way Forward
2022-01-18 06:30:00    
>> Lantern Pharma Announces Collaboration amp Research Agreement with The Danish Cancer Society Research Center to Support Clinical Development of Drug ...Lantern Pharma Announces Collaboration amp Research Agreement with The Danish Cancer Society Research Center to Support Clinical Development of Drug Candidates LP 100 and LP 184 in Solid Tumors
TODOS LOS TWEETS [ LTRN ]
HORA USUARIO TWEET
2022-06-15 12:26:29 MONICA
ltrn nasdaq stock rating changed to hold lantern pharma inc currently 3018 off the historical support price ...ltrn nasdaq stock rating changed to hold lantern pharma inc currently 3018 off the historical support price
2022-06-01 12:10:20 LEESINTRADE
ltrn stock trading ideas awaiting buy signal learn more at ...ltrn stock trading ideas awaiting buy signal learn more at
2022-06-01 09:58:46 HOT-STOCK
ltrn nasdaq rating upgraded to strong buy lantern pharma inc ...ltrn nasdaq rating upgraded to strong buy lantern pharma inc
2022-06-01 07:58:37 SHORTALGO
ltrn awaiting buy signal ...ltrn awaiting buy signal
2022-05-31 07:45:07 LUKIITASP
ltrn nasdaq stock rating changed to strong buy lantern pharma inc ...ltrn nasdaq stock rating changed to strong buy lantern pharma inc
2022-05-23 13:05:23 TRADINGMARKETCRYPTO
stock scalping 30mntime 20220523 170522long ltrn at 60tp 615sl 5928 ltrn ltrnjoin disco ...stock scalping 30mntime 20220523 170522long ltrn at 60tp 615sl 5928 ltrn ltrnjoin disco
2022-05-16 09:37:54 MICHAEL MøLLER
rt michaelmollerdk ipa comps aiantibodycovid stocksps lowest 2023 rev estltrn naigms 6857rlay 6522exai 4793a ...rt michaelmollerdk ipa comps aiantibodycovid stocksps lowest 2023 rev estltrn naigms 6857rlay 6522exai 4793a
2022-05-04 16:56:51 MIDEAST TIMES
lantern pharma ltrn releases earnings results ...lantern pharma ltrn releases earnings results
2022-05-04 16:50:26 TICKERON
ltrns in downtrend moving average convergence divergence macd histogram crosses below signal line view odds f ...ltrns in downtrend moving average convergence divergence macd histogram crosses below signal line view odds f
2022-05-03 11:00:28 TICKWATCHER
earnings todayp3ltrn lung lyft masi matx mcy mdxg mec mrcy mstr mtch mtw musa mx nr nrc nrds ...earnings todayp3ltrn lung lyft masi matx mcy mdxg mec mrcy mstr mtch mtw musa mx nr nrc nrds
2022-04-28 08:22:50 MONSTER2000
ltrn nasdaq stock rating changed to strong buy lantern pharma inc ...ltrn nasdaq stock rating changed to strong buy lantern pharma inc
2022-04-22 08:30:10 JIJO
ltrn ...ltrn
2022-04-22 08:20:07 MARKET WIRE NEWS
just in ltrn lantern pharma to report first quarter 2022 operating amp financial results on may 3rd 2022 at 430 p ...just in ltrn lantern pharma to report first quarter 2022 operating amp financial results on may 3rd 2022 at 430 p
2022-04-22 07:18:00 SHORTALGO
ltrn awaiting buy signal ...ltrn awaiting buy signal
2022-04-22 07:08:05 TRADE ALERTS, TRADE IDEAS AND CRYPTO
trending stocks ltrn lantern pharma inc trendingstocks april 22 2022 070000 am ... trending stocks ltrn lantern pharma inc trendingstocks april 22 2022 070000 am
2022-04-14 13:13:03 CHARTMILL
ltrn has a better quick ratio than 94 of its industry peers ...ltrn has a better quick ratio than 94 of its industry peers
2022-04-12 08:51:26 HéPHAïSTOS
rt redchip please join us april 14 at 415 pm et for the ltrn group investor call with more than 18 billion datapoints in their radr ai ...rt redchip please join us april 14 at 415 pm et for the ltrn group investor call with more than 18 billion datapoints in their radr ai
2022-04-12 08:51:21 REDCHIP
please join us april 14 at 415 pm et for the ltrn group investor call with more than 18 billion datapoints in th ...please join us april 14 at 415 pm et for the ltrn group investor call with more than 18 billion datapoints in th
2022-04-07 07:56:36 MAITE MERENDA
ltrn awaiting buy signal ...ltrn awaiting buy signal
2022-03-29 12:57:59 SPARROW INVESTS
36 pt trading at 722 ltrnoncology igms clvsholding a large position ...36 pt trading at 722 ltrnoncology igms clvsholding a large position
2022-03-29 12:57:23 SPARROW INVESTS
acinvestorblog oncology hot off igms still holding ltrn cancer research 34ptigms clvs ...acinvestorblog oncology hot off igms still holding ltrn cancer research 34ptigms clvs
2022-03-24 10:23:35 US BANKING NEWS
lantern pharma inc to post q1 2022 earnings of 044 per share colliers securities forecasts ltrn ...lantern pharma inc to post q1 2022 earnings of 044 per share colliers securities forecasts ltrn
[ [ Advertencia de riesgo ] ]

 Por favor, recuerda que el Trading es una actividad que pone en riesgo tu dinero y antes de hacerlo debes entender y aceptar los riesgos que eso supone. TradingCero.com no ofrece recomendaciones sobre Inversión ni sobre compra o venta de acciones ni de ningún activo financiero.


TradingCero.com es una web que ofrece información sobre los mercados financieros y Criptodivisas - información de la que no nos responsabilizamos si tuviera algún error - además de publicar cursos de Trading que nos parezcan de calidad e interesantes para nuestros lectores. TODA la información que compartimos así como las sesiones de TRADING que hacemos en nuestro CANAL DE YOUTUBE es SÓLO con FINES EDUCATIVOS.


Es posible que la información mostrada en la Web de TradingCero.com y en el Escáner de Acciones Americanas contenga errores de los que no nos responsabilizamos. Usamos fuentes de información de distintos proveedores por lo que no nos podemos hacer responsables de los errores contenidos en dicha información. Si ves algún error en esta web o en los datos que muestra, por favor, escríbemos un email a pablo@tradingcero.com y lo corregiremos lo antes posible.


TradingCero.com forma parte del programa de afiliados de la Escuela de Trading Tradenet.com y como tal, no nos podemos responsabilizar de los errores o problemas incluídos en sus paquetes formativos y/o servicios profesionales que ofrezca como Escuela de Trading.


Puedes consultar nuestro aviso legal, política de privacidad y política de cookies cuándo lo desees !